You just read:

Frontier Pharma: Hepatitis C - Diverse Range of First-in-Class Host-Targeting and Direct-Acting Antivirals Offer Potential in Difficult-to-Treat Populations

News provided by

ReportBuyer

12 Jan, 2017, 14:32 ET